Princess Margaret Cancer Centre
See the following -
The Ontario Institute for Cancer Research and the Structural Genomics Consortium develop and give away new drug-like molecule to help crowd-source cancer research.
Through a novel open source approach the molecule has been made freely available to the cancer research community to help discover new therapeutic strategies for cancer patients sooner...Researchers from the Ontario Institute for Cancer Research (OICR) and the Structural Genomics Consortium (SGC) at the MaRS Discovery District in Toronto have developed a new drug prototype called OICR-9429 and made it freely available to the research community. Already research conducted by international groups using OICR-9429 has shown it to be effective in stopping cancer cell growth in breast cancer cell lines and a specific subtype of leukemia cells.
- Login to post comments
Building a sustainable community around cBioPortal
The cBioPortal for Cancer Genomics provides visualization, analysis and download of large-scale cancer genomics data sets. The code, which was developed at Memorial Sloan Kettering Cancer Center has recently been put into the public domain under a GNU Affero General Public License v3.0, and the Pistoia Alliance is exploring ways to build a sustainable community around it. Further project details can be found in IP3.The Pistoia Alliance will be holding a webinar to bring perspectives from the original developers, academic and pharma users, and a commercial open source solution provider, followed by a Q&A session.
- Login to post comments